Global Mastopexy Market Report and Forecast 2025-2034

The growth of the healthcare infrastructure in developing countries such as China, India, and Brazil is significantly influencing the mastopexy market. These nations are witnessing a rising demand for cosmetic breast lifting procedures, driven by greater affordability and access to advanced medical treatments. The breast lift procedure is increasingly combined with a breast implant, providing enhanced aesthetic results. However, the cost of breast lifting surgeries remains a key factor influencing patient decisions. The cost of breast implants ranges widely depending on the material and procedure complexity. Additionally, breast lift surgical procedures are becoming more common among younger patients, with a rising trend in breast lift in teenagers due to evolving beauty standards and social media influence. This growing demand, coupled with technological advancements, is expected to drive further market expansion.

Technique Insights

Based on technique, the full mastopexy segment held a significant market share, driven by the rising demand for breast lift surgeries. The full mastopexy procedure is commonly performed to address breast sagging, particularly in ageing women and post-pregnancy cases. Additionally, it plays a crucial role in reconstructive surgery for breast cancer patients, where excess tissue is removed to improve symmetry and comfort. Surgeons carefully eliminate excess skin and reposition breast tissue to enhance the aesthetic appearance of the patients, making it a preferred option for those seeking both functional and cosmetic improvements.

The Benelli-lollipop lift segment is expected to witness the fastest growth during the forecast period. It is commonly referred to as vertical lift or vertical mastopexy, which involves a key incision pattern for precise shaping. The technique focuses on removing excess skin horizontally, particularly around the nipple area. Additionally, it enables the reshaping of areolas, creating a more proportionate breast structure. This method utilises the natural tissue to achieve a firmer and more balanced contour, offering long-lasting aesthetic results with minimal scarring compared to traditional mastopexy techniques. 

End-use Insights

Based on end-use, the specialty clinics segment accounted for the largest market share in the mastopexy market, driven by the increasing demand for breast enhancement surgeries. These clinics are preferred due to their specialised expertise and personalised care, attracting a growing number of patients. The availability of skilled cosmetic professionals and advancements in surgical techniques have further boosted the segment’s growth. Additionally, the rising popularity of mastopexy among individuals seeking aesthetic improvements has led to an increase in surgical procedures, making specialty clinics a dominant force in the market.

In addition, the rising affordability and shorter recovery times have led to the increasing popularity of independent practices, supporting the expansion of cosmetic clinics. These facilities offer a wide range of cosmetic surgeries in a more personalised setting. On the other hand, hospitals have limited capacity to provide aesthetic procedures, as they require high-tech devices and equipment, along with highly trained specialists.

Regional Insights

North America held the largest market share in the mastopexy market, driven by the high demand for surgical breast lifts and aesthetic enhancements. According to the American Society of Plastic Surgeons, nearly 143,364  breast lift procedures were performed in 2022, marking a 30% rise from 2019. This surge has positioned mastopexy among the top cosmetic surgical procedures in the region. Additionally, the average cost of the procedure stands at USD 6,816 , further contributing to market revenue. Europe, known for its advanced medical aesthetics and growing demand for breast enhancement, is the second-largest market for mastopexy.

Asia Pacific is expected to witness the fastest CAGR in the mastopexy market, driven by rising awareness of women's health and increasing acceptance of aesthetic procedures. The developing healthcare infrastructure of the region is making advanced treatments more accessible. Additionally, the growing demand for cosmetic treatments in countries like China, India, and South Korea is accelerating market expansion. The presence of specialised clinics and skilled surgeons, along with rising medical tourism, is further boosting the adoption of mastopexy in the region.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Key Companies and Market Share Insights

The global mastopexy market is driven by the increasing population that is concerned about its aesthetic appearance bolstering the manufacturing of mastopexy devices. Some market players are undertaking strategic initiatives such as mergers and partnerships to strengthen their market presence and expand their product portfolio. For instance, Lumenis is a global leader in energy-based medical solutions, specialising in aesthetic, surgical, and ophthalmic applications. The company develops and commercialises advanced laser and light-based technologies used in various medical procedures. Lumenis operates in multiple countries, including the US, Germany, Japan, China, and India. In March  2021, Baring Private Equity Asia (BPEA) agreed to sell Lumenis’ Surgical Business to Boston Scientific for USD 1.07 billion. The acquisition was completed in September  2021, integrating Lumenis’ laser systems and accessories for urology and ENT procedures into Boston Scientific’s portfolio.

• Lumenis 
• SOLTA Medical
• Syneron Medical
• Galderma
• Allergan Inc. 
• Mentor Word Wide LLC 
• GC Aesthetics 
• Cynosure 
• Polytech Health & Aesthetics 
• Sientra

Global Mastopexy Market Segmentation